Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
01 2019
Historique:
received: 04 12 2017
accepted: 31 10 2018
entrez: 13 12 2018
pubmed: 13 12 2018
medline: 23 5 2019
Statut: ppublish

Résumé

Germinal center (GC) B cells feature repression of many gene enhancers to establish their characteristic transcriptome. Here we show that conditional deletion of Lsd1 in GCs significantly impaired GC formation, associated with failure to repress immune synapse genes linked to GC exit, which are also direct targets of the transcriptional repressor BCL6. We found that BCL6 directly binds LSD1 and recruits it primarily to intergenic and intronic enhancers. Conditional deletion of Lsd1 suppressed GC hyperplasia caused by constitutive expression of BCL6 and significantly delayed BCL6-driven lymphomagenesis. Administration of catalytic inhibitors of LSD1 had little effect on GC formation or GC-derived lymphoma cells. Using a CRISPR-Cas9 domain screen, we found instead that the LSD1 Tower domain was critical for dependence on LSD1 in GC-derived B cells. These results indicate an essential role for LSD1 in the humoral immune response, where it modulates enhancer function by forming repression complexes with BCL6.

Identifiants

pubmed: 30538335
doi: 10.1038/s41590-018-0273-1
pii: 10.1038/s41590-018-0273-1
pmc: PMC6294324
mid: NIHMS1511349
doi:

Substances chimiques

Bcl6 protein, mouse 0
DNA, Intergenic 0
Proto-Oncogene Proteins c-bcl-6 0
Histone Demethylases EC 1.14.11.-
KDM1a protein, mouse EC 1.14.11.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-96

Subventions

Organisme : NCI NIH HHS
ID : K99 CA212276
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA013106
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA220499
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Nat Med. 2004 Dec;10(12):1329-35
pubmed: 15531890
Nucleic Acids Res. 2014 Jun;42(11):e95
pubmed: 24852250
Nature. 2007 Apr 19;446(7138):882-7
pubmed: 17392792
Oncotarget. 2016 Oct 4;7(40):65923-65936
pubmed: 27588474
Nat Med. 2015 Oct;21(10):1190-8
pubmed: 26366712
Nat Genet. 2009 Jan;41(1):125-9
pubmed: 19098913
Cancer Cell. 2015 Jul 13;28(1):57-69
pubmed: 26175415
Immunity. 2016 Sep 20;45(3):497-512
pubmed: 27637145
Nat Struct Mol Biol. 2006 Jul;13(7):626-32
pubmed: 16799558
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91
pubmed: 24799436
J Exp Med. 2008 Sep 29;205(10):2437-48
pubmed: 18809711
Cancer Discov. 2017 Mar;7(3):322-337
pubmed: 28069569
J Immunol. 2012 May 1;188(9):4217-25
pubmed: 22450810
Cancer Cell. 2013 May 13;23(5):677-92
pubmed: 23680150
Cancer Cell. 2005 May;7(5):445-55
pubmed: 15894265
Immunity. 2017 Jun 20;46(6):1045-1058.e6
pubmed: 28636954
Blood. 2018 Apr 12;131(15):1730-1742
pubmed: 29453291
Cell. 2004 Dec 29;119(7):941-53
pubmed: 15620353
Cancer Cell. 2012 Apr 17;21(4):473-87
pubmed: 22464800
Cancer Discov. 2012 Nov;2(11):1004-23
pubmed: 23107779
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Cell. 2010 Apr 13;17(4):400-11
pubmed: 20385364
J Biol Chem. 2009 Jun 26;284(26):17775-82
pubmed: 19407342
Blood. 2005 Mar 1;105(5):1851-61
pubmed: 15550490
Cancer Cell. 2016 Aug 8;30(2):197-213
pubmed: 27505670
Nat Med. 2012 Mar 11;18(4):605-11
pubmed: 22406747
Mol Cell. 2005 Sep 16;19(6):857-64
pubmed: 16140033
Mol Cell Biol. 2009 Mar;29(6):1421-31
pubmed: 19124609
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):13956-61
pubmed: 16956976
Immunity. 2016 Sep 20;45(3):471-482
pubmed: 27653600
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Cancer Discov. 2017 Jan;7(1):38-53
pubmed: 27733359
Cell Rep. 2017 Apr 18;19(3):461-470
pubmed: 28423310
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Biol Chem. 2007 Jul 13;282(28):20070-4
pubmed: 17537733
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Rep. 2013 Aug 15;4(3):578-88
pubmed: 23911289
Nat Methods. 2017 Oct;14(10):959-962
pubmed: 28846090
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Biotechnol. 2015 Jun;33(6):661-7
pubmed: 25961408
Mol Cell Biol. 2010 Oct;30(20):4851-63
pubmed: 20713442
Leukemia. 2012 Sep;26(9):2039-51
pubmed: 22699452
Immunol Rev. 2006 Apr;210:67-85
pubmed: 16623765
Mol Cell. 2006 Aug 4;23(3):377-87
pubmed: 16885027
Nat Med. 2015 Oct;21(10):1199-208
pubmed: 26366710
PLoS One. 2016 Nov 22;11(11):e0166438
pubmed: 27875550
Elife. 2013 Jun 18;2:e00633
pubmed: 23795291
Trends Mol Med. 2014 Jun;20(6):343-52
pubmed: 24698494

Auteurs

Katerina Hatzi (K)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Huimin Geng (H)

Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Ashley S Doane (AS)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
Institute for Computational Biomedicine, Dept. of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

Cem Meydan (C)

Institute for Computational Biomedicine, Dept. of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

Reed LaRiviere (R)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Mariano Cardenas (M)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
High Throughput and Spectroscopy Resource Center, Rockefeller University, New York, NY, USA.

Cihangir Duy (C)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Hao Shen (H)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Maria Nieves Calvo Vidal (MNC)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.

Timour Baslan (T)

Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Helai P Mohammad (HP)

Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA, USA.

Ryan G Kruger (RG)

Cancer Epigenetics Department, GlaxoSmithKline, Collegeville, PA, USA.

Rita Shaknovich (R)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
Cancer Genetics Incorporated, Rutherford, NJ, USA.

Ann M Haberman (AM)

Department of Laboratory Medicine, Department of Immunobiology Yale University School of Medicine, New Haven, CT, USA.

Giorgio Inghirami (G)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Scott W Lowe (SW)

Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Howard Hughes Medical Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ari M Melnick (AM)

Department of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY, USA. amm2014@med.cornell.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH